Start for free
Start for free
BP

Biofrontier Partners

North America, California, United States, San Diego

Description

Founded in 2001, Biofrontier Partners is a California-based private equity company that also provides research and analysis solutions.

Investor Profile

Biofrontier Partners has made 10 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (40%)
  • Series C (30%)
  • Series D (20%)
  • Seed (10%)

Country Focus

  • United States (80%)
  • Germany (10%)
  • Japan (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Genetics
  • Pharmaceutical
  • Medical
  • Medical Device
  • Life Science
  • Therapeutics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biofrontier Partners frequently co-invest with?

CSK Venture Capital
CSK Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Sanderling Ventures
Sanderling Ventures
North America, California, United States, San Mateo
Co-Investments: 2
CMEA Ventures
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 2
CC
CMEA Capital
North America, California, United States, San Francisco
Co-Investments: 2
BS
BSI SA
Europe, Ticino, Switzerland, Lugano
Co-Investments: 2
Unilever Ventures
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 3
SL
SB Life Science
North America, California, United States, Redwood City
Co-Investments: 3
CS
Cape Securities
North America, Georgia, United States, Mcdonough
Co-Investments: 2
Maverick Ventures
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Brookside Capital
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does Biofrontier Partners often collaborate with?

AZ
Alejandro Zaffaroni
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Biofrontier Partners?

Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DJan 6, 2006
Amount Raised: $50,000,000
BioTrove

Woburn, Massachusetts, United States

Gene Analysis

BiotechnologyGeneticsHealth CareLife Science
Series BJul 16, 2005
Amount Raised: $5,000,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DFeb 28, 2005
Amount Raised: $74,000,000
BioTrove

Woburn, Massachusetts, United States

Gene Analysis

BiotechnologyGeneticsHealth CareLife Science
Series BJan 29, 2004
Amount Raised: $10,900,000
CellZome

Heidelberg, Baden-Wurttemberg, Germany

CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CMar 17, 2003
Amount Raised: $31,959,671
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series CJan 28, 2003
Amount Raised: $30,000,000
CardioNet

Conshohocken, Pennsylvania, United States

CardioNet provides real-time ambulatory outpatient management solutions to monitor clinical information of people.

BiotechnologyHealth CareMedical Device
Series CJan 13, 2003
Amount Raised: $13,000,000
AnGes

Tokyo, Tokyo, Japan

AnGes MG, Inc. is a biopharmaceutical company with a mission to provide patients, especially those suffering from disease.

BiopharmaBiotechnologyGeneticsHealth Care
SeedSep 25, 2002
Salmedix

San Diego, California, United States

It focuses on the treatment of hematologic malignancies or blood cancers.

BiotechnologyHealth CareMedical
Series BJun 19, 2002
Amount Raised: $27,500,000
CardioNet

Conshohocken, Pennsylvania, United States

CardioNet provides real-time ambulatory outpatient management solutions to monitor clinical information of people.

BiotechnologyHealth CareMedical Device
Series BMay 1, 2000
Amount Raised: $6,900,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator